Articles Tagged With:
-
ED Push - January 2016 Second Issue
-
Compliance Mentor - January 2016
-
EPs Often Unaware of Psychiatric Patients’ EMTALA Risks
Screening must cover both medical and mental health.
-
Complacency Is Risky for Frequent ED Users with Psychiatric History
Assumptions of “same old” symptoms are dangerous.
-
Assuming Patient’s Symptoms ‘Just Psychiatric’ Is Legally Risky
EPs sometimes assume that delusions, hallucinations, agitation, and other psychiatric complaints are due to a psychiatric illness without performing a complete history and physical examination.
-
Psych Patients Held in ED for Days Create Legal Risks for EPs
Some patients discharged without evaluation.
-
Did Your ED Examine a Mass Shooter?
Lawsuit could allege inadequate evaluation; EPs could be liable for violent acts of patients.
-
One In Five Cancer Clinical Trials Fail To Meet Patient Accrual Targets
A new study explores the reasons why some cancer clinical trials fold early.
-
FDA Actions
In this section: The FDA may soon recommend against using codeine for pain and cough in children underage children; vitamin D supplementation may not prevent elderly falls after all; agency approves insulin glargine for the treatment of diabetes; and mepolizumab for maintenance treatment of asthma when used with other asthma medications receives approval.
-
Comparing Type 2 Diabetes Drug Therapies
A new evidence review compares the weekly glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes.